Health News Desk,More than 55 million people all over the world are suffering from Alzheimer’s disease. But it is a matter of concern that at present there is no cure for this disease, which can definitely claim to be cured. However, some progress has been made in recent times in efforts to find a cure for Alzheimer’s. Most clinical trials looking at the effectiveness of these drugs, begin treatment only after the onset of symptoms. This means that the damage caused to the body by this disease has already happened. However, it is believed that if the treatment of patients suffering from this disease is started.
Disease will be known 10 years ago!
A recent study by the Karolinska Institute calls for the use of a different biomarker than the one currently used for the diagnosis of Alzheimer’s, reports news agency PTI. The study found that a biomarker, which can be found in a person’s blood, could detect Alzheimer’s up to 10 years before symptoms begin. This offers a chance to prevent its entry into the body before symptoms appear or emerge. The study, led by Caroline Graf and Charlotte Johansson, looked at Swedish families with a form of Alzheimer’s disease caused by a genetic mutation. data has been used. If a parent has ADAD, their children have a 50 percent chance of passing the mutation on.
What is GFAP?
According to the study, other tests such as MRI imaging and cognitive tests were also done to look for signs of the disease. The key finding in this study was that the level of a specific protein, called GFAP, increased before other known prognostic blood-based biomarkers were analyzed in the study.